SpectraWAVE
About SpectraWAVE
SpectraWAVE is a medical device company specializing in advanced intravascular imaging and physiological assessment technologies, primarily focused on improving the treatment and outcomes for patients with coronary artery disease (CAD). Their flagship product, the HyperVue™ Imaging System, is an AI-enabled platform that integrates next-generation DeepOCT™ (Optical Coherence Tomography) and Near-Infrared Spectroscopy (NIRS). This combination provides interventional cardiologists with comprehensive optical and computational insights into plaque morphology, composition, and vessel anatomy, aiding in optimal stent intervention and identifying plaques at risk of future coronary adverse events.
Beyond imaging, SpectraWAVE has developed the X1-FFR software, an AI-enabled, wire-free, drug-free solution that provides fractional flow reserve (FFR) assessment from a single angiogram. This technology aims to simplify and accelerate FFR results, eliminating the need for invasive pressure wires and streamlining workflows in the cardiac catheterization lab. The company’s innovations are designed to enhance clinical decision-making, optimize percutaneous coronary intervention (PCI) procedures, and ultimately improve patient care by offering simpler, faster, and better imaging and physiological assessment.
As of December 2025, SpectraWAVE was acquired by Royal Philips, further integrating its breakthrough, AI-powered technologies into Philips’ image-guided therapy portfolio to expand options for clinicians in the cath lab.
Focus Areas
Business Intelligence
| Key Investors | Deerfield Management, Johnson & Johnson Innovation (JJDC), S3 Ventures, Lumira Ventures, SV Health Investors, Nova Venture Partners, LLC, Heartwork Capital |
| Acquisitions | Acquired by Philips (December 2025) |
| Technology | HyperVue Imaging System (DeepOCT™ + NIRS), X1-FFR (AI-enabled, wire-free, drug-free, single angiogram physiology solution), AI-based image analysis and automated measurements, Image co-registration with angiography |
| FDA Clearances | 5 cleared products (estimated) |
What Physicians Need to Know
For physicians, SpectraWAVE's integrated HyperVue Imaging System with DeepOCT+NIRS and the X1-FFR software offers a powerful diagnostic hub for coronary artery disease. This platform provides unparalleled insights into plaque morphology and composition, enabling more precise and personalized treatment strategies. The AI-enabled automated analysis significantly reduces interpretation time and variability, while the wire-free FFR streamlines workflow, enhances patient comfort, and accelerates decision-making in the cath lab. Leveraging this technology can lead to optimized PCI outcomes, reduced adverse events, and improved long-term patient prognosis by providing a more complete picture of the coronary vasculature. The ability to visualize the entire arterial wall and accurately detect lipid-rich plaques and calcium is particularly valuable for identifying high-risk lesions and guiding stent selection and deployment.
SpectraWAVE has been acquired by Philips. Their HyperVue Imaging System and X1-FFR technology are being integrated into Philips' existing intravascular imaging and physiology ecosystem, including the Eagle Eye Platinum digital IVUS, IntraSight technologies, and the Azurion image-guided therapy platform. This integration aims to expand clinicians' intravascular imaging toolbox and offer a comprehensive, orchestrated system for tailored guidance in coronary interventions.
What the Web Says
SpectraWAVE is a medical imaging company that develops innovative technologies for coronary care, including the HyperVue Imaging System and X1-FFR for angiogram-derived physiology. While their products are praised by healthcare professionals for their advanced features and ease of use, employee reviews paint a mixed to negative picture of the company culture.
Overall: MixedStrengths
- Advanced imaging and physiology technologies (DeepOCT, NIRS, X1-FFR).
- AI-enabled workflows for simplified and faster results.
- Wire-free and drug-free physiology measurements.
- Single angiogram per vessel for accurate FFR values.
- Easy-to-use system with positive clinical and early commercial feedback.
- Competitive salaries in engineering and research & development departments.
Limitations
- Extremely toxic workplace culture.
- Harassment and discrimination are reportedly tolerated or encouraged.
- Lack of adequate human resources support.
- Management prioritizes profits over employee well-being.
- Leadership team primarily focused on money, with reports of degradation and threats.
- Lower salaries in administration and plant/manufacturing departments.
Based on reviews from: Zippia, Diagnostic and Interventional Cardiology, FDA OKs SpectraWAVE's AI-Powered Angiogram Physiology Software, Business Wire, SpectraWAVE, Inc. | Medical Imaging | United States, First-in-Human Experience With a Novel Multimodality DeepOCT-NIRS Intracoronary Imaging System - PMC
Last updated: 2026-07-19
Videos
News, demos, and interviews about SpectraWAVE.
Videos load interactively. If none appear, search YouTube for SpectraWAVE →
Press & Coverage
Frequently Asked Questions
Related Companies
Clarista is a healthcare AI company that focuses on building a “trust layer” for enterprise AI, particularly within regulated industries like healthcare and financial services. The company’s platform aims to address the challenges of data fragmentation, governance, and compliance that often hinder the successful implementation of AI projects in large organizations. Clarista’s technology unifies structured […]
HelloBooks.ai is an AI-powered accounting software company that aims to automate and simplify financial management for small businesses, freelancers, and accounting professionals. The platform utilizes generative AI to handle repetitive bookkeeping tasks such as transaction categorization, receipt capture, bank reconciliation, and report generation. It is designed to reduce manual data entry and improve accuracy, allowing […]
Vero, also known as Vero.ai, is an artificial intelligence company specifically designed to augment clinical workflows and improve patient care within the healthcare sector. Their primary focus is on leveraging AI to streamline administrative tasks, enhance diagnostic accuracy, and personalize treatment plans. By automating routine processes, Vero aims to free up healthcare professionals’ time, allowing […]
Ant Group, a global digital technology provider and operator of Alipay, has significantly expanded its focus into healthcare AI. The company recently upgraded its physician platform, Haodf for Doctor, into ‘AQ for Doctor,’ an AI-powered workstation designed to support physicians across various stages of clinical practice, including online consultations, patient management, clinical decision support, and […]
e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]
PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]